Mrs Jennifer Ann Brown, MS CCC-SLP/L | |
215 Maple Cir, Green River, WY 82935-4765 | |
(307) 871-5732 | |
Not Available |
Full Name | Mrs Jennifer Ann Brown |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 215 Maple Cir, Green River, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437660131 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SP-861 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jennifer Ann Brown, MS CCC-SLP/L 215 Maple Cir, Green River, WY 82935-4765 Ph: (307) 871-5732 | Mrs Jennifer Ann Brown, MS CCC-SLP/L 215 Maple Cir, Green River, WY 82935-4765 Ph: (307) 871-5732 |
News Archive
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the US Food and Drug Administration (FDA) approved using the injections to help patients with neurological conditions who suffer from incontinence, or an overactive bladder.
The widely practised procedure of suctioning babies to prevent a potentially fatal respiratory disease is probably ineffective, conclude authors of a study in this week's issue of THE LANCET. Suctioning is used to remove mucus from baby's airway or breathing passages.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pancreatic neuroendocrine tumors (NET) in patients with unresectable locally advanced or metastatic disease. Pancreatic NET is a rare cancer reported in two to four people per million annually worldwide.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
People with a history of cancer have a 40 percent greater likelihood of experiencing memory problems that interfere with daily functioning, compared with those who have not had cancer, according to results of a new, large study.
› Verified 6 days ago
Christa J Vandervort, SP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1400 Uinta Dr, Green River, WY 82935 Phone: 307-872-4500 Fax: 307-872-4595 | |
Cara Elizabeth Straw, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1045 Washakie Ave, Green River, WY 82935 Phone: 307-871-1115 | |
Diane Kurth, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1715 Hitching Post Dr, Green River, WY 82935 Phone: 307-872-3290 | |
Christy Calvey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1715 Hitching Post Dr, Green River, WY 82935 Phone: 307-872-3290 |